Cerebras Systems Nasdaq IPO

Cerebras closed its first session at $311.07 for a market cap of roughly $95 billion on 2025 revenue of $510 million, putting the stock at approximately 187x trailing sales ^[1]. The same screen shows Nvidia at ~26x, AMD at ~21x and Broadcom at ~33x ^[1]— meaning new CBRS holders are paying a roughly 7x revenue-multiple premium over the category leader that prints record AI margins quarter after quarter. Jim Cramer told CNBC viewers the math simply doesn't support chasing the stock and recommended waiting for a pullback ^[1]. The bull counterargument, articulated by PitchBook's Dimitri Zabelin, is that the AI workload mix is shifting from training (where Nvidia is entrenched) to inference (where Cerebras's wafer-scale architecture is genuinely differentiated) ^[2]. CEO Andrew Feldman frames the technical case bluntly: 'We built a chip the size of a dinner plate. It's 58 times larger than any chip previously built' ^[3], with reported inference speedups of up to 15x over GPUs ^[3]. The market is therefore not buying 2025 revenue — it is buying a thesis that inference becomes the dominant AI compute spend bucket and that wafer-scale silicon takes meaningful share of it. The Motley Fool noted the same structural read, arguing the print reframes how investors will value the entire non-GPU AI hardware market and positions CBRS for likely S&P 500 and Nasdaq-100 inclusion ^[4]. Whether 187x is visionary or vertigo depends on a single variable nobody can yet measure: inference unit economics in 2027.

The disclosure most readers missed in the prospectus is the arithmetic of who pays Cerebras's bills. MBZUAI alone accounted for 62% of 2025 revenue and 77.9% of year-end accounts receivable; combined with G42 the two UAE-linked related parties drove 86% of total 2025 revenue ^[2]. The OpenAI Master Relationship Agreement signed in January 2026 was designed precisely to break that dependence — a $20B+ commitment for 750 MW of inference capacity expandable to 2 GW by 2030 ^[6]. But that contract carries its own asymmetry: Morningstar's Brian Colello notes the OpenAI deal structure includes equity warrants and a ~$1B loan component, and Cerebras's own filing discloses an OpenAI warrant for up to 33.4 million Class N shares at a $0.00001 strike ^[2][5]. So the same anchor customer that justified the IPO multiple is also being handed a near-free option on a chunk of the cap table. Reddit's r/wallstreetbets and r/stocks split sharply between cautious bulls and outright bears on exactly this point, with the bear thesis crystallized as: OpenAI is itself burning cash, so a Cerebras revenue line backstopped by OpenAI commitments is only as good as OpenAI's ability to keep raising. The CFIUS-driven restructuring of G42 to non-voting shares ^[8]solved the national-security problem but did not solve the concentration problem — it simply rotated the counterparty risk from a sovereign-linked Gulf customer to a private U.S. company that has yet to demonstrate cash-flow positive operations. That is the real story buried inside the celebratory headlines.

The 2026 debut is not Cerebras's first attempt. The company filed its initial S-1 on September 30, 2024 and was almost immediately forced to pause when CFIUS opened a review of G42's stake ^[8]. At that point G42 was Cerebras's largest customer and a meaningful equity holder — a Gulf entity with prior U.S. national-security scrutiny, plugged directly into the company's revenue line. The CFIUS overhang made a 2024 listing impossible at any price. The unlock arrived in March 2025, when Cerebras restructured G42's equity into non-voting shares and CFIUS cleared the deal ^[8]. That restructuring was followed in October 2025 by a $1.1B Series G at an $8.1B valuation led by Fidelity and Atreides — a financing that bought the company time to walk into public markets on its own schedule rather than out of necessity ^[8]. Then came the two contracts that rewrote the story: the OpenAI $20B+ Master Relationship Agreement in January 2026 ^[6]and the AWS binding term sheet in March 2026 that made AWS the first hyperscaler to deploy Cerebras systems in its own data centers under a disaggregated-inference model (Trainium for prefill, Cerebras for decode) ^[7]. Eighteen months separated the dead-on-arrival 2024 S-1 from a $5.55B blockbuster — and the difference was almost entirely about replumbing the cap table and the customer list, not the silicon.

Cerebras was the first major U.S. tech IPO of this scale in years and the first true AI-pureplay listing at hyperscaler-comparable valuations ^[4]. The 20x oversubscription ^[9], the twice-raised price range ^[9], and the day-one print signal that public-market appetite for AI infrastructure is not satiated by Nvidia alone. The Next Web reports the debut is already being read as the opening shot for a wave of long-deferred listings from SpaceX, OpenAI and Anthropic ^[10]. The signaling is structural: lead underwriters Morgan Stanley, Citi, Barclays and UBS now have a fresh comp for pricing AI-infrastructure deals well above traditional growth-software multiples ^[11], and the index-inclusion tailwind for CBRS gives passive flows a tangible new AI-hardware bucket ^[4]. The cautionary footnote arrived 24 hours later, when CBRS slid roughly 10% on day two as buyers reassessed the multiple and the disclosures ^[12][13]. For the next issuer in the queue, the read is double-edged: the window is open, but it is open for stories that combine an inference-era technical thesis with a marquee customer contract — and even then, demand evaporates fast if the customer-concentration footnotes look ugly under the second-day microscope.